Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 33,200 | 130,500 | 109,800 | 82,000 | 45,900 |
| Depreciation Amortization | 13,400 | 56,800 | 42,200 | 28,400 | 14,200 |
| Income taxes - deferred | 3,100 | 7,100 | -3,700 | -4,800 | 2,700 |
| Accounts receivable | 2,900 | 3,400 | -3,500 | -9,900 | -2,200 |
| Other Working Capital | -18,300 | -12,200 | -10,100 | -16,300 | -6,200 |
| Other Operating Activity | 2,000 | 47,100 | 26,100 | 21,200 | 6,600 |
| Operating Cash Flow | $36,300 | $232,700 | $160,800 | $100,600 | $61,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -200 | -1,900 | N/A | N/A | N/A |
| PPE Investments | -13,600 | -35,200 | -40,000 | -9,300 | -2,300 |
| Net Acquisitions | -9,500 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -900 | -1,800 | -1,500 | -1,400 | -700 |
| Sale Of Investment | N/A | 400 | 14,700 | N/A | N/A |
| Purchase Sale Intangibles | N/A | -2,000 | -2,000 | -2,000 | -2,100 |
| Other Investing Activity | 2,400 | 900 | -1,500 | -1,900 | -2,100 |
| Investing Cash Flow | $-21,800 | $-37,600 | $-28,300 | $-12,600 | $-5,100 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 17,600 | 54,800 | 42,000 | 29,100 | 12,800 |
| Debt Repayment | -29,400 | -140,700 | -110,200 | -70,600 | -40,700 |
| Common Stock Issued | 11,700 | 33,500 | 26,200 | 17,900 | 7,700 |
| Common Stock Repurchased | -24,800 | -145,900 | -127,200 | -85,900 | -29,400 |
| Other Financing Activity | 8,100 | 4,700 | 7,900 | 9,000 | 4,600 |
| Financing Cash Flow | $-16,800 | $-193,600 | $-161,300 | $-100,500 | $-45,000 |
| Exchange Rate Effect | -300 | 2,700 | 1,500 | 1,000 | -300 |
| Beginning Cash Position | 182,800 | 178,600 | 178,600 | 178,600 | 178,600 |
| End Cash Position | 180,200 | 182,800 | 151,300 | 167,100 | 189,200 |
| Net Cash Flow | $-2,600 | $4,200 | $-27,300 | $-11,500 | $10,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | 36,300 | 232,700 | 160,800 | 100,600 | 61,000 |
| Capital Expenditure | -13,600 | -57,400 | -40,000 | -24,000 | -8,000 |
| Free Cash Flow | 22,700 | 175,300 | 120,800 | 76,600 | 53,000 |